North America Home Infusion Therapy Market Size & Outlook
North America home infusion therapy market, 2018-2030 (US$M)
Related Markets
North America home infusion therapy market highlights
- The North America home infusion therapy market generated a revenue of USD 20,216.7 million in 2023.
- The market is expected to grow at a CAGR of 7.5% from 2024 to 2030.
- In terms of segment, anti-infective was the largest revenue generating application in 2023.
- Chemotherapy is the most lucrative application segment registering the fastest growth during the forecast period.
- Country-wise, U.S. is expected to register the highest CAGR from 2024 to 2030.
North America data book summary
| Market revenue in 2023 | USD 20,216.7 million |
| Market revenue in 2030 | USD 33,448.5 million |
| Growth rate | 7.5% (CAGR from 2023 to 2030) |
| Largest segment | Anti-infective |
| Fastest growing segment | Chemotherapy |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Anti-Infective, Endocrinology, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals |
| Key market players worldwide | CVS Group PLC, Walgreens Boots Alliance Inc, UnitedHealth Group Inc, BrightSpring Health Services Inc, Fresenius Medical Care AG, ICU Medical Inc, B. Braun Medical, Baxter International Inc, BD, Smiths Group PLC, Terumo Corp, Caesarea Medical Electronics |
Other key industry trends
- In terms of revenue, North America region accounted for 56.2% of the global home infusion therapy market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 10,305.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Home Infusion Therapy Market Scope
Home Infusion Therapy Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America home infusion therapy market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to home infusion therapy market will help companies and investors design strategic landscapes.
Anti-infective was the largest segment with a revenue share of 27.02% in 2023. Horizon Databook has segmented the North America home infusion therapy market based on anti-infective, endocrinology, hydration therapy, chemotherapy, enteral nutrition, parenteral nutrition, specialty pharmaceuticals covering the revenue growth of each sub-segment from 2018 to 2030.
The home infusion therapy market in North America is expected to witness a significant growth during the forecast period owing to factors such as high adoption of home infusion therapies and introduction of technologically advanced products. Major factors driving market growth include increase in geriatric population and rise in disease burden. In addition, growing awareness has led to a higher inclination of patients, especially geriatric population, requiring long-term care toward home infusion therapy.
It has been estimated that administration of medications at home costs from USD 150 to USD 200 per day, much lesser than the cost of a typical inpatient stay, which costs from USD 1,500 to USD 2,500 per day. The North American home infusion therapy market was expected to be impacted due to the introduction of the Cures Act and lose its share to hospital-affiliated infusion centers, physician centers, and other alternate site settings. However, introduction of several other acts, such as Bipartisan Budget Act of 2018, would help the region regain its market share.
The Bipartisan Budget Act of 2018 is expected to have a positive impact on the growth of the home infusion therapy market in the U.S. Section 50401 of this act creates a temporary reimbursement for clinical services related to Medicare Part B durable medical equipment home infusion drugs. The act was likely to be effective from January 2019 and allow patients or Medicare beneficiaries to access home infusion therapies at home until a permanent services reimbursement is implemented in 2021.
Reasons to subscribe to North America home infusion therapy market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America home infusion therapy market databook
-
Our clientele includes a mix of home infusion therapy market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America home infusion therapy market , including forecasts for subscribers. This continent databook contains high-level insights into North America home infusion therapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America home infusion therapy market size, by country, 2018-2030 (US$M)
North America Home Infusion Therapy Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
